Voxtur Bio Limited (Voxtur Bio) Return Comparision with Primex 40 Index

Periods	1 Week	1 Month	3 Months	6 Months	1 Year	3 Years	All Time
Primex-40
Voxtur Bio Limited

Voxtur Bio Limited Consolidated Balance Sheet (Rs in Thousands)

Particulars	31-03-2024	31-03-2023
Equity
Share Capital	63,710.32	63,710.32
Reserves and surplus	2,38,111.26	1,92,660.72
Non-current liabilities
Long term borrowings	75,799.65	44,627.27
Long term provisions	783.84	645.08
Current Liabilities
Short term borrowings	1,63,939.50	54,418.37
Trade payables	2,64,983.38	1,32,943.03
Other current liabilities	40,496.24	15,335.01
Short term provisions	178.90	151.39
Total Equity and Liabilities	8,48,003.09	5,04,491.19
Non-current Assets
Tangible assets	37,390.61	45,785.36
Intangible assets	8,331.80	12,771.52
Deferred tax assets	2,056.60	6,141.36
Long term loans and advances	29,838.49	30,861.66
Other non-current assets	6,747.37	3,139.91
Current Assets
Inventories	1,84,384.19	1,38,620.86
Trade receivables	5,47,584.89	2,24,951.77
Cash and bank balances	1,481.88	917.60
Short term loans and advances	29,499.75	40,591.05
Other current assets	687.51	710.10
Total Assets	8,48,003.09	5,04,491.19

Voxtur Bio Limited Consolidated Profit & Loss Statement (Rs in Thousands)

Particulars	31-03-2024	31-03-2023
Revenue
Revenue from sale of products	5,13,529.64	3,72,781.99
Revenue from sale of services	87.43	143.18
Other Income	187.41	116.08
Total Revenue	5,13,804.48	3,73,041.25
Expenses
Cost of material consumed	3,26,544.30	2,81,698.29
Changes in inventories	27,472.31	-42,721.55
Employee benefit expenses	19,937.32	18,396.40
Finance cost	18,631.59	9,207.86
Depreciation expenses	8,781.38	10,964.21
Amortisation expenses	4,439.72	4,735.68
Other expenses	40,337.40	49,647.78
Total Expenses	4,46,144.02	3,31,928.67
Profit Before tax	67,660.46	41,112.58
Current Tax	18,125.16	-
Deferred tax	4,084.76	8,697.11
Total Profit/(Loss) for the period	45,450.54	32,415.47
Earnings per share
Basic	7.13	5.09
Diluted	7.13	5.09

Voxtur Bio Limited Consolidated Cash Flow Statement (Rs in Thousands)

Particulars	31-03-2024	31-03-2023
Cash flows from Operating activities
Profit before extraordinary items and tax	67,660.46	41,112.58
Adjustments for:
Depreciation and amortisation expense	13,221.10	15,699.88
Non-cash items	18,452.93	9,091.78
Decrease (increase) in inventories	-45,763.33	-61,729.63
Decrease (increase) in trade receivables	-3,22,633.12	-86,200.27
Decrease (increase) in other current assets	22.60	-27.20
Increase (decrease) in trade payables	1,32,040.35	56,068.53
Increase (decrease) in other current liabilities	25,161.23	3,003.58
Provisions	166.27	120.37
Net cash flows from (used in) operations	-1,11,671.51	-22,860.38
Income taxes paid (refund)	17,449.62	353.56
Other inflows (outflows) of cash	6,808.29	1,286.41
Net cash flows from (used in) operating activities	-1,22,312.84	-21,927.53
Cash flows from Investing activities
Purchase of tangible assets	386.63	363.84
Interest received	178.66	116.08
Other inflows (outflows) of cash	1,023.17	15,780.23
Net cash flows from (used in) investing activities	815.20	15,532.47
Cash flows from Financing activities
Proceeds from borrowings	1,40,693.51	12,828.68
Other inflows (outflows) of cash	-18,631.59	-9,207.86
Net cash flows from (used in) financing activities	1,22,061.92	3,620.82
Net increase (decrease) in cash and cash equivalents	564.28	-2,774.24
Cash and cash equivalents cash flow statement at end of period	1,481.88	917.60

Summary of the Cash Flow Statement for the years 2024 and 2023:

The company’s operating activities show a significant cash outflow in both years, with a much larger deficit in 2023-24. Despite reporting a profit before tax of ₹67,660.46 thousand in FY 2023-24 (higher than ₹41,112.58 thousand in FY 2022-23), the operating cash flow turned negative mainly due to substantial increases in trade receivables and inventories, indicating that funds were tied up in working capital. The sharp rise in receivables (₹3,22,633.12 thousand) and inventory buildup (₹45,763.33 thousand) drained cash. Although increases in trade payables and other liabilities provided some positive cash adjustments, they were not enough to offset the heavy working-capital absorption. As a result, net cash used in operations amounted to ₹1,22,312.84 thousand in 2023-24, compared to ₹21,927.53 thousand in the previous year.

Cash flows from investing activities remained relatively modest. In FY 2023-24, the company recorded a small net inflow of ₹815.20 thousand, mainly driven by inflows from other investing-related cash movements, despite purchases of tangible assets. In contrast, FY 2022-23 saw a significantly higher investing cash inflow of ₹15,532.47 thousand, primarily due to larger "other inflows" related to investments. Overall, investing activities contributed positively in both years, though with a sharp decline in 2023-24.

The company’s financing activities played a crucial role in offsetting the operating cash deficit. During FY 2023-24, the firm generated a strong inflow of ₹1,22,061.92 thousand, mainly due to substantial borrowings of ₹1,40,693.51 thousand. This helped compensate for the negative operational cash flow. In FY 2022-23, financing inflows were significantly smaller at ₹3,620.82 thousand, reflecting relatively lower borrowing needs or availability.